Chlorine in PDB 6p8m: Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C

The structure of Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C, PDB code: 6p8m was solved by C.Weidle, M.Pancera, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	50.00 / 3.59
Space group	C 2 2 2
Cell size a, b, c (Å), α, β, γ (°)	146.796, 176.755, 108.573, 90.00, 90.00, 90.00
R / Rfree (%)	23.2 / 26.8

The structure of Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C also contains other interesting chemical elements:

Sodium

(Na)

4 atoms

The binding sites of Chlorine atom in the Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C (pdb code 6p8m). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C, PDB code: 6p8m:

Chlorine binding site 1 out of 1 in the Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Antibody P-P3B3 A60C Heavy Chain in Complex with 426C Hiv-1 GP120 Core G459C within 5.0Å range: probe atom residue distance (Å) B Occ C:Cl1411 b:0.1 occ:1.00 HB2 C:SER375 2.8 70.0 1.0 OG C:SER375 2.9 64.5 1.0 CB C:SER375 3.3 58.2 1.0 HA C:PHE376 3.5 50.9 1.0 N C:PHE376 3.6 40.7 1.0 C C:SER375 3.7 44.5 1.0 HG C:SER375 3.7 77.6 1.0 HD1 C:PHE382 3.7 68.9 1.0 H C:PHE376 3.8 49.0 1.0 HG12 C:VAL255 3.9 69.0 1.0 O C:SER375 4.0 57.7 1.0 CA C:PHE376 4.0 42.2 1.0 HB3 C:SER375 4.1 70.0 1.0 CA C:SER375 4.1 49.8 1.0 HG3 C:GLU370 4.1 63.4 1.0 HG23 C:THR257 4.2 75.4 1.0 HE2 C:MET475 4.4 74.5 1.0 HA C:SER256 4.5 56.0 1.0 C C:PHE376 4.5 45.3 1.0 CD1 C:PHE382 4.6 57.3 1.0 HE1 C:PHE382 4.6 76.8 1.0 HA C:SER375 4.6 60.0 1.0 HG11 C:VAL255 4.6 69.0 1.0 CG1 C:VAL255 4.7 57.3 1.0 HG2 C:GLU370 4.7 63.4 1.0 CG C:GLU370 4.8 52.7 1.0 HD1 C:TRP427 4.8 85.5 1.0 O C:PHE376 4.9 47.6 1.0 OH C:TYR384 4.9 34.7 1.0 HB3 C:GLU370 4.9 66.9 1.0 HH C:TYR384 5.0 41.9 1.0 HE1 C:MET475 5.0 74.5 1.0 HH2 C:TRP112 5.0 60.0 1.0

K.R.Parks, A.Maccamy, J.Trichka, M.Gray, C.Weidle, A.Borst, A.Khechaduri, B.Takushi, J.Guenaga, R.Wyatt, R.Coler, C.Labranche, D.Veesler, D.C.Montefiori, M.Pancera, A.Mcguire, L.Stamatatos. Overcoming Key Steric Restrictions in the Maturation of VRC01-Class Hiv-1 Neutralizing Antibodies During Immunization To Be Published.